{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:21Z","timestamp":1793082801905,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pbb.2024.173883","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:20:02Z","timestamp":1727126402000},"page":"173883","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain"],"prefix":"10.1016","volume":"245","author":[{"given":"Elise M.","family":"Weerts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan W.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbie Y.","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Hausker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine F.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.pbb.2024.173883_bb0005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"19\u201320","key":"10.1016\/j.pbb.2024.173883_bb0010","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00213-016-4397-4","article-title":"Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats","volume":"233","author":"Brierley","year":"2016","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2024.173883_bb0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/FBP.0000000000000285","article-title":"A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats","volume":"28","author":"Brierley","year":"2017","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173883_bb0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173883_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"issue":"1","key":"10.1016\/j.pbb.2024.173883_bb0030","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1038\/s41598-024-66879-0","article-title":"Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial","volume":"14","author":"Cuttler","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.pbb.2024.173883_bb0035","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0040","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2024.173883_bb0045","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1124\/jpet.121.000497","article-title":"Behavioral battery for testing candidate analgesics in mice. II. Effects of endocannabinoid catabolic enzyme inhibitors and \u22069-tetrahydrocannabinol","volume":"377","author":"Diester","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"312","key":"10.1016\/j.pbb.2024.173883_bb0050","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/01621459.1965.10480843","article-title":"The up-and-down method for small samples","volume":"60","author":"Dixon","year":"1965","journal-title":"J. Am. Stat. Assoc."},{"issue":"4","key":"10.1016\/j.pbb.2024.173883_bb0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2024.173883_bb0060","first-page":"222","article-title":"Pharmacotherapy of anxiety disorders: current and emerging treatment options","volume":"19","author":"Garakani","year":"2021","journal-title":"Focus (Am. Psychiatr. Publ.)"},{"key":"10.1016\/j.pbb.2024.173883_bb0065","series-title":"Curr Protoc Neurosci Chapter 8, Unit 8 17","article-title":"Assessment of murine startle reactivity, prepulse inhibition, and habituation","author":"Geyer","year":"2003"},{"issue":"7","key":"10.1016\/j.pbb.2024.173883_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071992","article-title":"In vitro model of neuroinflammation: efficacy of cannabigerol, a non-psychoactive cannabinoid","volume":"19","author":"Gugliandolo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pbb.2024.173883_bb0075","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1124\/jpet.102.045120","article-title":"Anxiogenic effects of neurosteroid exposure: sex differences and altered GABAA receptor pharmacology in adult rats","volume":"305","author":"Gulinello","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pbb.2024.173883_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.pbb.2024.173883_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12061145","article-title":"Single and combined effects of Cannabigerol (CBG) and Cannabidiol (CBD) in mouse models of oxaliplatin-associated mechanical sensitivity, opioid antinociception, and naloxone-precipitated opioid withdrawal","volume":"12","author":"Hayduk","year":"2024","journal-title":"Biomedicines"},{"issue":"S1","key":"10.1016\/j.pbb.2024.173883_bb0090","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1089\/can.2023.0083","article-title":"Evaluating potential anxiolytic effects of minor cannabinoids and terpenes after acute and chronic oral administration in rats","volume":"8","author":"Jenkins","year":"2023","journal-title":"Cannabis Cannabinoid Res."},{"issue":"8","key":"10.1016\/j.pbb.2024.173883_bb0095","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/s41386-019-0387-7","article-title":"Voluntary oral consumption of Delta(9)-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood","volume":"44","author":"Kruse","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.pbb.2024.173883_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084277","article-title":"Paclitaxel-associated mechanical sensitivity and neuroinflammation are sex-, time-, and site-specific and prevented through cannabigerol administration in C57Bl\/6 mice","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/FBP.0b013e32814fcdd4","article-title":"Comparative effects of nonselective and subtype-selective gamma-aminobutyric acidA receptor positive modulators in the rat-conditioned emotional response test","volume":"18","author":"Mathiasen","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173883_bb0115","doi-asserted-by":"crossref","first-page":"1183019","DOI":"10.3389\/fphar.2023.1183019","article-title":"Cannabigerol modulates alpha(2)-adrenoceptor and 5-HT(1A) receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat","volume":"14","author":"Mendiguren","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173883_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.31","article-title":"Cannabinoid-induced tetrad in mice","volume":"80","author":"Metna-Laurent","year":"2017","journal-title":"Curr. Protoc. Neurosci."},{"issue":"5","key":"10.1016\/j.pbb.2024.173883_bb0125","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00213-021-05995-5","article-title":"Cannabinoid tetrad effects of oral Delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations","volume":"239","author":"Moore","year":"2022","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2024.173883_bb0130","series-title":"Delta(9)-Tetrahydrocannabinol Vapor Exposure Produces Conditioned Place Preference in Male and Female Rats","author":"Moore","year":"2022"},{"key":"10.1016\/j.pbb.2024.173883_bb0135","series-title":"Submission","article-title":"Cognitive and motivational effects of cannabigerol in male and female rats","author":"Moore","year":"2024"},{"issue":"2","key":"10.1016\/j.pbb.2024.173883_bb0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1124\/jpet.120.000340","article-title":"The pharmacological case for cannabigerol","volume":"376","author":"Nachnani","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.pbb.2024.173883_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ph16101442","article-title":"Chronic cannabigerol as an effective therapeutic for cisplatin-induced neuropathic pain","volume":"16","author":"Nachnani","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pbb.2024.173883_bb0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2018.00632","article-title":"Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes","volume":"9","author":"Navarro","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0155","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.pbb.2012.10.008","article-title":"Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability","volume":"103","author":"O'Brien","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.pbb.2024.173883_bb0160","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog. Neurobiol."},{"issue":"1","key":"10.1016\/j.pbb.2024.173883_bb0165","volume":"20","author":"Peters","year":"2023","journal-title":"J. Int. Soc. Sports Nutr."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-010-2157-4","article-title":"Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews","volume":"215","author":"Rock","year":"2011","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2024.173883_bb0175","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s00213-018-5034-1","article-title":"Effect of cannabidiolic acid and \u2206(9)-tetrahydrocannabinol on carrageenan-induced hyperalgesia and edema in a rodent model of inflammatory pain","volume":"235","author":"Rock","year":"2018","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2024.173883_bb0180","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1089\/can.2021.0058","article-title":"Survey of patients employing cannabigerol-predominant cannabis preparations: perceived medical effects, adverse events, and withdrawal symptoms","volume":"7","author":"Russo","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"issue":"5","key":"10.1016\/j.pbb.2024.173883_bb0185","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1037\/0735-7044.102.5.748","article-title":"The catalepsy test: its ups and downs","volume":"102","author":"Sanberg","year":"1988","journal-title":"Behav. Neurosci."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0190","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(00)00044-3","article-title":"Activational role of cannabinoids on movement","volume":"391","author":"Sanudo-Pena","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2024.173883_bb0195","series-title":"Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain. J. Pharmacol. Exp. Ther","author":"Schwarz","year":"2024"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2024.173883_bb0200","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pain.2004.01.020","article-title":"Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat","volume":"109","author":"Scott","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.pbb.2024.173883_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107761","article-title":"Role of the PACAP system of the extended amygdala in the acoustic startle response in rats","volume":"160","author":"Seiglie","year":"2019","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pbb.2024.173883_bb0210","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ejp.2016","article-title":"Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy-induced peripheral neuropathy","volume":"26","author":"Sepulveda","year":"2022","journal-title":"Eur. J. Pain"},{"issue":"5","key":"10.1016\/j.pbb.2024.173883_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267498","article-title":"The phytochemical diversity of commercial Cannabis in the United States","volume":"17","author":"Smith","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2024.173883_bb0220","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.copsyc.2019.04.002","article-title":"Changing landscape of cannabis: novel products, formulations, and methods of administration","volume":"30","author":"Spindle","year":"2019","journal-title":"Curr. Opin. Psychol."},{"key":"10.1016\/j.pbb.2024.173883_bb0225","article-title":"Habituation and prepulse inhibition of acoustic startle in rodents","volume":"55","author":"Valsamis","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"3","key":"10.1016\/j.pbb.2024.173883_bb0230","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenin-induced edema in hind paw of the rat as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.pbb.2024.173883_bb0235","series-title":"The Cannabis Constituent Cannabigerol Does Not Disrupt Fear Memory Processes or Stress-Induced Anxiety in Mice. Cannabis Cannabinoid Res","author":"Zhou","year":"2021"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305724001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:51:23Z","timestamp":1733233883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305724001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S0091305724001771"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173883","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Orally administered Cannabigerol (CBG) in rats: Cannabimimetic actions, anxiety-like behavior, and inflammation-induced pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2024.173883","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"173883"}}